Correlation Between Scpharmaceuticals and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Oncolytics Biotech, you can compare the effects of market volatilities on Scpharmaceuticals and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Oncolytics Biotech.
Diversification Opportunities for Scpharmaceuticals and Oncolytics Biotech
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Scpharmaceuticals and Oncolytics is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Oncolytics Biotech
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.52 times more return on investment than Oncolytics Biotech. However, Scpharmaceuticals is 1.91 times less risky than Oncolytics Biotech. It trades about -0.01 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.12 per unit of risk. If you would invest 331.00 in Scpharmaceuticals on October 20, 2024 and sell it today you would lose (3.00) from holding Scpharmaceuticals or give up 0.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Oncolytics Biotech
Performance |
| Timeline |
| Scpharmaceuticals |
| Oncolytics Biotech |
Scpharmaceuticals and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Oncolytics Biotech
The main advantage of trading using opposite Scpharmaceuticals and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Oncolytics Biotech vs. Scpharmaceuticals | Oncolytics Biotech vs. Milestone Pharmaceuticals | Oncolytics Biotech vs. Seres Therapeutics | Oncolytics Biotech vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |